DE602005018941D1 - Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation - Google Patents

Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation

Info

Publication number
DE602005018941D1
DE602005018941D1 DE602005018941T DE602005018941T DE602005018941D1 DE 602005018941 D1 DE602005018941 D1 DE 602005018941D1 DE 602005018941 T DE602005018941 T DE 602005018941T DE 602005018941 T DE602005018941 T DE 602005018941T DE 602005018941 D1 DE602005018941 D1 DE 602005018941D1
Authority
DE
Germany
Prior art keywords
medicaments
extracts
treatment
winterberry
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018941T
Other languages
English (en)
Inventor
Mario Baraldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sofar SpA
Original Assignee
Mario Baraldi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Baraldi filed Critical Mario Baraldi
Publication of DE602005018941D1 publication Critical patent/DE602005018941D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/02—Pretreatment
    • C11B1/04—Pretreatment of vegetable raw material

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005018941T 2004-10-01 2005-09-28 Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation Active DE602005018941D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001871A ITMI20041871A1 (it) 2004-10-01 2004-10-01 Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce
PCT/EP2005/010481 WO2006037535A2 (en) 2004-10-01 2005-09-28 The use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation

Publications (1)

Publication Number Publication Date
DE602005018941D1 true DE602005018941D1 (de) 2010-03-04

Family

ID=36113810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018941T Active DE602005018941D1 (de) 2004-10-01 2005-09-28 Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation

Country Status (14)

Country Link
US (1) US7976878B2 (de)
EP (1) EP1793840B1 (de)
JP (1) JP4995727B2 (de)
KR (1) KR20070057849A (de)
CN (1) CN101043898B (de)
AT (1) ATE454897T1 (de)
AU (1) AU2005291507B2 (de)
CA (1) CA2582317A1 (de)
DE (1) DE602005018941D1 (de)
IL (1) IL182297A (de)
IT (1) ITMI20041871A1 (de)
NO (1) NO20071671L (de)
RU (1) RU2007111457A (de)
WO (1) WO2006037535A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102344367A (zh) * 2010-08-06 2012-02-08 苏州瑞蓝博中药技术开发有限公司 一种从薄荷中提取迷迭香酸的方法
JP5986793B2 (ja) * 2012-04-26 2016-09-06 小川香料株式会社 セイボリーエキスの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010040C2 (de) * 1980-03-15 1985-05-02 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur Gewinnung von Rosmarinsäure aus Melisse
AU3734999A (en) * 1998-05-16 1999-12-06 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
CN1277037A (zh) * 2000-06-20 2000-12-20 李凤祥 治疗心脑血管病与性功能减退的药物及其制备方法
US7086403B2 (en) * 2000-12-05 2006-08-08 Church & Dwight Co., Inc. Condom with male genital desensitizer lubricant
WO2002062365A1 (fr) * 2001-02-01 2002-08-15 Meiji Seika Kaisha, Ltd. Procede de production d'un extrait vegetal de lamiacee contenant des phenols, et utilisation de ce dernier
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition

Also Published As

Publication number Publication date
NO20071671L (no) 2007-04-27
US7976878B2 (en) 2011-07-12
KR20070057849A (ko) 2007-06-07
ITMI20041871A1 (it) 2005-01-01
AU2005291507B2 (en) 2010-08-05
EP1793840B1 (de) 2010-01-13
CA2582317A1 (en) 2006-04-13
US20080199542A1 (en) 2008-08-21
EP1793840A2 (de) 2007-06-13
WO2006037535A2 (en) 2006-04-13
AU2005291507A1 (en) 2006-04-13
CN101043898B (zh) 2012-12-12
RU2007111457A (ru) 2008-10-10
IL182297A0 (en) 2008-04-13
IL182297A (en) 2010-12-30
WO2006037535A3 (en) 2006-07-13
JP4995727B2 (ja) 2012-08-08
JP2008514666A (ja) 2008-05-08
ATE454897T1 (de) 2010-01-15
CN101043898A (zh) 2007-09-26

Similar Documents

Publication Publication Date Title
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE518841T1 (de) Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
TN2010000237A1 (en) Novel compounds and compositions and methods of use
DE602005018981D1 (de) Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
ATE542536T1 (de) 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
ATE516040T1 (de) Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE602005018941D1 (de) Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
WO2005077397A3 (en) Methods and compositions for treating vascular diseases
DE60335892D1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SOFAR S.P.A., MAILAND/MILANO, IT

8364 No opposition during term of opposition